<DOC>
	<DOCNO>NCT01716130</DOCNO>
	<brief_summary>To assess acceptance Fluzone Intradermal ( ID ) vaccine adult vaccine administrator United States . Patients complete 2 survey , one immediately post-vaccination one seven day later , document demographic assessed injection pain , injection anxiety , speed injection , overall satisfaction , preference next year 's vaccine . Vaccine administrator complete one survey assess ease vaccine preparation administration , time require administer , safety/risk needle stick injury patient administrator .</brief_summary>
	<brief_title>Acceptability Fluzone Intradermal Vaccine Patients Vaccine Administrators</brief_title>
	<detailed_description>Patients divide two group : 1 ) report receive intramuscular ( IM ) influenza vaccine past 3 year ; 2 ) report receive IM influenza vaccine past 3 year . The survey response compare two group . In addition , subject report receive IM vaccine past 3 year ask compare experience IM vaccine versus ID vaccine .</detailed_description>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Age 18 64 year age Desire receive Fluzone Intradermal vaccine protect influenza . Less 18 year age , 65 year age old . Desire receive Fluzone Intramuscular vaccine protect influenza . problem immune system , current illness , severe allergy egg , severe ( life threaten ) allergy , history GuillainBarre Syndrome ( severe paralytic illness ) receive flu vaccine past three month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Fluzone Intradermal vaccine</keyword>
</DOC>